Advances In Pediatric Hematopoietic Cell Therapies And Transplantation

  • 17k

    Total downloads

  • 83k

    Total views and downloads

About this Research Topic

Submission closed

Background

There have been significant advances in hematopoietic cell transplantation and cellular therapy in recent years. Allogeneic hematopoietic cell transplantation (alloHCT) offers curative treatment for numerous malignant and non-malignant disorders and has evolved into a relatively safe procedure with reduced transplant related mortality. However, graft-versus-host-disease, viral infections and disease relapse remain a significant complication of alloHCT. Recent advances to improve the safety and efficacy of alloHCT have included more refined conditioning regimens, in vivo or in vitro graft engineering, broader donor options including the resurgence of haploidentical donor HCT, and improved supportive care. Moreover, an assortment of novel cell therapies primarily against cancer but also against infections are seeing broader application.

The majority of alloHCT are being performed as curative therapy for pediatric acute leukemias. Relapse remains a leading cause of mortality in patients receiving alloHCT for hematologic malignancies. Exploiting immune reconstitution to enhance graft versus tumor (GvT) effects, while restraining graft versus host disease (GvHD) and controlling viral reactivation remain areas of intense research. HCT is now more widely applied in patients with hemoglobinopathies and bone marrow failure syndromes. Hematopoietic cell therapies most notably chimeric antigen receptor (CAR)-T cells but also natural killer (NK), gamma-delta -T cells, cytokine induced killer (CIK) and viral specific T cells have seen significant development in recent years offering salvage and/or preventative treatments to pediatric patients.

This article collection will provide recent advances in the field of pediatric hematopoietic cell transplantation and adoptive cell therapy. We particularly welcome the following themes:

• Cell and gene therapies for sickle cell disease
• T-cell immunotherapy for pediatric brain tumors
• Minor H antigen-specific T cells
• Immune reconstitution post-BMT
• Viral T-cell therapy
• NK cell therapies
• CAR-T cells
• T cell therapies
• Haploidentical BMT for hematologic malignancies
• Haploidentical BMT for neuroblastoma
• Cytokine induced killer cells
• Advances in gamma delta T-cell therapy
• Cell therapies for solid tumors
• HCT for Fanconi anemia
• Mesenchymal stem or stromal cells:
• Are CAR T cells better than antibody or HCT therapy in B-ALL
• Transplants for bone marrow failure syndrome
• BMT for Hemoglobinophathies
• Graft engineering strategies for PBSC transplantation
• Cell therapy to promote tolerance in transplant for non-malignant diseases
• Haploidentical BMT for Aplastic Anemia
• Immune recovery and GvL
• Cord blood transplantation

Dr Patrick Hanley, a Topic Editor for this collection, is a co-founder and serves on the board of directors of Mana Therapeutics, a private biotech company focused on cellular therapy for AML.

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Frequently asked questions

  • Frontiers' Research Topics are collaborative hubs built around an emerging theme.Defined, managed, and led by renowned researchers, they bring communities together around a shared area of interest to stimulate collaboration and innovation.

    Unlike section journals, which serve established specialty communities, Research Topics are pioneer hubs, responding to the evolving scientific landscape and catering to new communities.

  • The goal of Frontiers' publishing program is to empower research communities to actively steer the course of scientific publishing. Our program was implemented as a three-part unit with fixed field journals, flexible specialty sections, and dynamically emerging Research Topics, connecting communities of different sizes and maturity.

    Research Topics originate from the scientific community. Many of our Research Topics are suggested by existing editorial board members who have identified critical challenges or areas of interest in their field.

  • As an editor, Research Topics will help you build your journal, as well as your community, around emerging, cutting-edge research. As research trailblazers, Research Topics attract high-quality submissions from leading experts all over the world.

    A thriving Research Topic can potentially evolve into a new specialty section if there is sustained interest and a growing community around it.

  • Each Research Topic must be approved by the specialty chief editor, and it falls under the editorial oversight of our editorial boards, supported by our in-house research integrity team. The same standards and rigorous peer review processes apply to articles published as part of a Research Topic as for any other article we publish.

    In 2023, 80% of the Research Topics we published were edited or co-edited by our editorial board members, who are already familiar with their journal's scope, ethos, and publishing model. All other topics are guest edited by leaders in their field, each vetted and formally approved by the specialty chief editor.

  • Publishing your article within a Research Topic with other related articles increases its discoverability and visibility, which can lead to more views, downloads, and citations. Research Topics grow dynamically as more published articles are added, causing frequent revisiting, and further visibility.

    As Research Topics are multidisciplinary, they are cross-listed in several fields and section journals – increasing your reach even more and giving you the chance to expand your network and collaborate with researchers in different fields, all focusing on expanding knowledge around the same important topic.

    Our larger Research Topics are also converted into ebooks and receive social media promotion from our digital marketing team.

  • Frontiers offers multiple article types, but it will depend on the field and section journals in which the Research Topic will be featured. The available article types for a Research Topic will appear in the drop-down menu during the submission process.

    Check available article types here 

  • Yes, we would love to hear your ideas for a topic. Most of our Research Topics are community-led and suggested by researchers in the field. Our in-house editorial team will contact you to talk about your idea and whether you’d like to edit the topic. If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. 

    Suggest your topic here 

  • A team of guest editors (called topic editors) lead their Research Topic. This editorial team oversees the entire process, from the initial topic proposal to calls for participation, the peer review, and final publications.

    The team may also include topic coordinators, who help the topic editors send calls for participation, liaise with topic editors on abstracts, and support contributing authors. In some cases, they can also be assigned as reviewers.

  • As a topic editor (TE), you will take the lead on all editorial decisions for the Research Topic, starting with defining its scope. This allows you to curate research around a topic that interests you, bring together different perspectives from leading researchers across different fields and shape the future of your field. 

    You will choose your team of co-editors, curate a list of potential authors, send calls for participation and oversee the peer review process, accepting or recommending rejection for each manuscript submitted.

  • As a topic editor, you're supported at every stage by our in-house team. You will be assigned a single point of contact to help you on both editorial and technical matters. Your topic is managed through our user-friendly online platform, and the peer review process is supported by our industry-first AI review assistant (AIRA).

  • If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. This provides you with valuable editorial experience, improving your ability to critically evaluate research articles and enhancing your understanding of the quality standards and requirements for scientific publishing, as well as the opportunity to discover new research in your field, and expand your professional network.

  • Yes, certificates can be issued on request. We are happy to provide a certificate for your contribution to editing a successful Research Topic.

  • Research Topics thrive on collaboration and their multi-disciplinary approach around emerging, cutting-edge themes, attract leading researchers from all over the world.

  • As a topic editor, you can set the timeline for your Research Topic, and we will work with you at your pace. Typically, Research Topics are online and open for submissions within a few weeks and remain open for participation for 6 – 12 months. Individual articles within a Research Topic are published as soon as they are ready.

    Find out more about our Research Topics

  • Our fee support program ensures that all articles that pass peer review, including those published in Research Topics, can benefit from open access – regardless of the author's field or funding situation.

    Authors and institutions with insufficient funding can apply for a discount on their publishing fees. A fee support application form is available on our website.

  • In line with our mission to promote healthy lives on a healthy planet, we do not provide printed materials. All our articles and ebooks are available under a CC-BY license, so you can share and print copies.